- ►diabetesjournals.org E Arikawa, RCW Ma, K Isshiki, I Luptak, Z He … - Diabetes, 2007 - Am Diabetes Assoc High-density oligonucleotide arrays were used to compare gene expression of rat
hearts from control, untreated diabetic, and diabetic groups treated with islet
cell transplantation (ICT), protein kinase C (PKC)β inhibitor ... Cited by 12 - Related articles - BL Direct - All 5 versions
E Arikawa, RCW Ma, K Isshiki, I Luptak, Z He … - Am Diabetes Assoc Emi Arikawa†, Ronald CW Ma†, Keiji Isshiki, Ivan Luptak, Zhiheng He, Yutaka
Yasuda, Yasuhiro Maeno, Mary Elizabeth Patti, Gordon C. Weir, Robert A. Harris,
Victor A. Zammit, Rong Tian, George L. King From Joslin Diabetes Center, ... Related articles
O Bilim, Y Takeishi, T Kitahara, T Arimoto, T … - Cardiovascular diabetology, 2008 - cardiab.com We examined transgenic mice with cardiac-specific overexpression of DGKζ
(DGKζ-TG) compared to wild type (WT) mice in streptozotocin-induced (STZ, 150
mg/kg) diabetic and nondiabetic conditions. After 8 weeks, decreases in ... Cited by 3 - Related articles - Cached - All 10 versions
M Harada, Y Takeishi, T Arimoto, T Niizeki, T … - Circ J, 2007 - sciencelinks.jp Abstract;Background The Gaq protein-coupled receptor (GPCR) signaling pathway,
which includes diacylglycerol (DAG) and protein kinase C (PKC), plays a critical
role in the development of cardiac hypertrophy and heart failure. DAG ... Cited by 12 - Related articles - Cached - BL Direct - All 3 versions
- ►oxfordjournals.org KA Connelly, DJ Kelly, Y Zhang, DL Prior, J … - Cardiovascular Research, 2007 - cardiovascres.oxfordjournals.org Results Diabetic Ren-2 rats developed impairment of both active and passive
phases of diastole, accompanied by reductions in SERCA-2a ATPase and
phospholamban along with activation of the fetal gene program. Structural ... Cited by 10 - Related articles - All 4 versions
M KAWAGUCHI, T ASAKURA, F SAITO, O … - Journal of cardiology, 1999 - sciencelinks.jp TOP > J-EAST > List of Journal Titles (J) > J Cardiol(1999) > Changes in
Diameter Size and F-Actin Expression in the Myocytes of Patients With Diabetes
and Streptozotocin-Induced Diabetes Model Rats. ... Changes in Diameter ... Cited by 10 - Related articles - Cached - BL Direct - All 3 versions
J Chiu, H Farhangkhoee, BY Xu, S Chen, B … - Journal of Molecular and Cellular Cardiology, 2008 - Elsevier Diabetic cardiomyopathy is characterized by structural alterations such as
cardiomyocyte hypertrophy, necrosis and focal fibrosis. Hyperglycemia-induced
oxidative damage may play an important role in this pathogenetic process. ... Cited by 4 - Related articles - All 17 versions
- ►physiology.org DJ Kelly, Y Zhang, K Connelly, AJ Cox, J … - American Journal of Physiology- Heart and Circulatory …, 2007 - Am Physiological Soc Diastolic dysfunction is an increasingly recognized complication of diabetes
that develops in relatively young patients as a result of diabetic
cardiomyopathy (DCM). With recent advances in echocardiographic technology ... Cited by 4 - Related articles - BL Direct - All 4 versions
P Liu, YJ Xu, RL Hopfner, V Gopalakrishnan - BBA-Molecular and Cell Biology of Lipids, 1999 - Elsevier Phosphatidic acid (PA), which can be synthesized de novo, or as a product of
phosphatidylcholine hydrolysis and/or phosphorylation of 1,2-diacylglycerol
(DAG), mediates diverse cellular functions in various cell types, including ... Cited by 5 - Related articles - All 4 versions
MK Topham, SM Prescott - Thrombosis and haemostasis, 2002 - cat.inist.fr Diacylglycerol kinases(DGKs) are thought to attenuate diacylglycerol signals by
converting diacylglycerol to phosphatidic acid. The nine mammalian
diacylglycerol kinases that have been identified are widely expressed, but ... Cited by 25 - Related articles - BL Direct - All 3 versions
